plantar warts
Conditions
Interventions
Group A :pingyangmycin dissolvable microneedle
Group B:iquid nitrogen frozen
Sponsors
Shanghai Skin Disease Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-70 years, no gender limit; 2. Sign informed consent before the test, and fully understand the test content, process and possible adverse reactions; 3. Patients with clinically confirmed plantar warts caused by HPV infection; 4. Patients with plantar warts who underwent no local or systemic treatment within 3 months; 5. The patient is willing to voluntarily take effective contraceptive measures within 6 months after signing the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with Pingyangmycin allergy; 2. Patients with lung, liver and kidney dysfunction; 3. Lesions associated with other infected persons; 4. Pregnant or lactating patients; 5. Not suitable for cryotherapy; 6. Other conditions in which the researcher judged that they could not participate in the experiment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical cure rate of target of lesions ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analog scale (VAS) was used to assess pain indicators;Adverse reactions; | — |
Countries
China
Contacts
Public ContactLiu Xiaoping
Shanghai Skin Disease Hospital
Outcome results
None listed